Global Molecular Diagnostics Point of Care Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Molecular Diagnostics Point of Care market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The Molecular Diagnostics Point of Care enables physicians to improve the standard of care by combining rapid diagnosis with treatment decisions during the first patient visit.
This report is a detailed and comprehensive analysis for global Molecular Diagnostics Point of Care market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Molecular Diagnostics Point of Care market size and forecasts, in consumption value ($ Million), 2018-2029
Global Molecular Diagnostics Point of Care market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Molecular Diagnostics Point of Care market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Molecular Diagnostics Point of Care market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Diagnostics Point of Care
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Diagnostics Point of Care market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Abaxis, Bayer Healthcare, Bio-Rad Laboratories and Becton Dickinson and Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Molecular Diagnostics Point of Care market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Molecular Diagnostics Point of Care product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Diagnostics Point of Care, with revenue, gross margin and global market share of Molecular Diagnostics Point of Care from 2018 to 2023.
Chapter 3, the Molecular Diagnostics Point of Care competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Molecular Diagnostics Point of Care market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Diagnostics Point of Care.
Chapter 13, to describe Molecular Diagnostics Point of Care research findings and conclusion.
The Molecular Diagnostics Point of Care enables physicians to improve the standard of care by combining rapid diagnosis with treatment decisions during the first patient visit.
This report is a detailed and comprehensive analysis for global Molecular Diagnostics Point of Care market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Molecular Diagnostics Point of Care market size and forecasts, in consumption value ($ Million), 2018-2029
Global Molecular Diagnostics Point of Care market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Molecular Diagnostics Point of Care market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Molecular Diagnostics Point of Care market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Diagnostics Point of Care
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Diagnostics Point of Care market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Abaxis, Bayer Healthcare, Bio-Rad Laboratories and Becton Dickinson and Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Molecular Diagnostics Point of Care market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Assays and Kits
- Instruments and Analyzers
- Software and Services
- Others
- Tumor
- Hematology
- Endocrinology
- Infectious Disease
- Others
- Abbott Laboratories
- Abaxis
- Bayer Healthcare
- Bio-Rad Laboratories
- Becton Dickinson and Company
- Binx Health
- BioMerieux
- Co-Diagnostics
- DanaherCorporation
- Dako
- F. Hoffmann
- OraSure Technologies
- Roche Diagnostics
- Nipro Diagnostics
- Genestat
- Meridian Bioscience
- Molbio Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific
- Visby Medical
- Wuhan Easy Diagnosis Biomedicine
- Beijing Tiandz
- Beijing Content
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Molecular Diagnostics Point of Care product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Diagnostics Point of Care, with revenue, gross margin and global market share of Molecular Diagnostics Point of Care from 2018 to 2023.
Chapter 3, the Molecular Diagnostics Point of Care competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Molecular Diagnostics Point of Care market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Diagnostics Point of Care.
Chapter 13, to describe Molecular Diagnostics Point of Care research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Molecular Diagnostics Point of Care
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Molecular Diagnostics Point of Care by Type
1.3.1 Overview: Global Molecular Diagnostics Point of Care Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Molecular Diagnostics Point of Care Consumption Value Market Share by Type in 2022
1.3.3 Assays and Kits
1.3.4 Instruments and Analyzers
1.3.5 Software and Services
1.3.6 Others
1.4 Global Molecular Diagnostics Point of Care Market by Application
1.4.1 Overview: Global Molecular Diagnostics Point of Care Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Tumor
1.4.3 Hematology
1.4.4 Endocrinology
1.4.5 Infectious Disease
1.4.6 Others
1.5 Global Molecular Diagnostics Point of Care Market Size & Forecast
1.6 Global Molecular Diagnostics Point of Care Market Size and Forecast by Region
1.6.1 Global Molecular Diagnostics Point of Care Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Molecular Diagnostics Point of Care Market Size by Region, (2018-2029)
1.6.3 North America Molecular Diagnostics Point of Care Market Size and Prospect (2018-2029)
1.6.4 Europe Molecular Diagnostics Point of Care Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Molecular Diagnostics Point of Care Market Size and Prospect (2018-2029)
1.6.6 South America Molecular Diagnostics Point of Care Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Molecular Diagnostics Point of Care Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Product and Solutions
2.1.4 Abbott Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Abaxis
2.2.1 Abaxis Details
2.2.2 Abaxis Major Business
2.2.3 Abaxis Molecular Diagnostics Point of Care Product and Solutions
2.2.4 Abaxis Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abaxis Recent Developments and Future Plans
2.3 Bayer Healthcare
2.3.1 Bayer Healthcare Details
2.3.2 Bayer Healthcare Major Business
2.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Product and Solutions
2.3.4 Bayer Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bayer Healthcare Recent Developments and Future Plans
2.4 Bio-Rad Laboratories
2.4.1 Bio-Rad Laboratories Details
2.4.2 Bio-Rad Laboratories Major Business
2.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Product and Solutions
2.4.4 Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.5 Becton Dickinson and Company
2.5.1 Becton Dickinson and Company Details
2.5.2 Becton Dickinson and Company Major Business
2.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Product and Solutions
2.5.4 Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Becton Dickinson and Company Recent Developments and Future Plans
2.6 Binx Health
2.6.1 Binx Health Details
2.6.2 Binx Health Major Business
2.6.3 Binx Health Molecular Diagnostics Point of Care Product and Solutions
2.6.4 Binx Health Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Binx Health Recent Developments and Future Plans
2.7 BioMerieux
2.7.1 BioMerieux Details
2.7.2 BioMerieux Major Business
2.7.3 BioMerieux Molecular Diagnostics Point of Care Product and Solutions
2.7.4 BioMerieux Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 BioMerieux Recent Developments and Future Plans
2.8 Co-Diagnostics
2.8.1 Co-Diagnostics Details
2.8.2 Co-Diagnostics Major Business
2.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Product and Solutions
2.8.4 Co-Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Co-Diagnostics Recent Developments and Future Plans
2.9 DanaherCorporation
2.9.1 DanaherCorporation Details
2.9.2 DanaherCorporation Major Business
2.9.3 DanaherCorporation Molecular Diagnostics Point of Care Product and Solutions
2.9.4 DanaherCorporation Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 DanaherCorporation Recent Developments and Future Plans
2.10 Dako
2.10.1 Dako Details
2.10.2 Dako Major Business
2.10.3 Dako Molecular Diagnostics Point of Care Product and Solutions
2.10.4 Dako Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Dako Recent Developments and Future Plans
2.11 F. Hoffmann
2.11.1 F. Hoffmann Details
2.11.2 F. Hoffmann Major Business
2.11.3 F. Hoffmann Molecular Diagnostics Point of Care Product and Solutions
2.11.4 F. Hoffmann Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 F. Hoffmann Recent Developments and Future Plans
2.12 OraSure Technologies
2.12.1 OraSure Technologies Details
2.12.2 OraSure Technologies Major Business
2.12.3 OraSure Technologies Molecular Diagnostics Point of Care Product and Solutions
2.12.4 OraSure Technologies Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 OraSure Technologies Recent Developments and Future Plans
2.13 Roche Diagnostics
2.13.1 Roche Diagnostics Details
2.13.2 Roche Diagnostics Major Business
2.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Product and Solutions
2.13.4 Roche Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Roche Diagnostics Recent Developments and Future Plans
2.14 Nipro Diagnostics
2.14.1 Nipro Diagnostics Details
2.14.2 Nipro Diagnostics Major Business
2.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Product and Solutions
2.14.4 Nipro Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Nipro Diagnostics Recent Developments and Future Plans
2.15 Genestat
2.15.1 Genestat Details
2.15.2 Genestat Major Business
2.15.3 Genestat Molecular Diagnostics Point of Care Product and Solutions
2.15.4 Genestat Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Genestat Recent Developments and Future Plans
2.16 Meridian Bioscience
2.16.1 Meridian Bioscience Details
2.16.2 Meridian Bioscience Major Business
2.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Product and Solutions
2.16.4 Meridian Bioscience Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Meridian Bioscience Recent Developments and Future Plans
2.17 Molbio Diagnostics
2.17.1 Molbio Diagnostics Details
2.17.2 Molbio Diagnostics Major Business
2.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Product and Solutions
2.17.4 Molbio Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Molbio Diagnostics Recent Developments and Future Plans
2.18 Siemens Healthcare
2.18.1 Siemens Healthcare Details
2.18.2 Siemens Healthcare Major Business
2.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Product and Solutions
2.18.4 Siemens Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Siemens Healthcare Recent Developments and Future Plans
2.19 Thermo Fisher Scientific
2.19.1 Thermo Fisher Scientific Details
2.19.2 Thermo Fisher Scientific Major Business
2.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Product and Solutions
2.19.4 Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.20 Visby Medical
2.20.1 Visby Medical Details
2.20.2 Visby Medical Major Business
2.20.3 Visby Medical Molecular Diagnostics Point of Care Product and Solutions
2.20.4 Visby Medical Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Visby Medical Recent Developments and Future Plans
2.21 Wuhan Easy Diagnosis Biomedicine
2.21.1 Wuhan Easy Diagnosis Biomedicine Details
2.21.2 Wuhan Easy Diagnosis Biomedicine Major Business
2.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product and Solutions
2.21.4 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Wuhan Easy Diagnosis Biomedicine Recent Developments and Future Plans
2.22 Beijing Tiandz
2.22.1 Beijing Tiandz Details
2.22.2 Beijing Tiandz Major Business
2.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Product and Solutions
2.22.4 Beijing Tiandz Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Beijing Tiandz Recent Developments and Future Plans
2.23 Beijing Content
2.23.1 Beijing Content Details
2.23.2 Beijing Content Major Business
2.23.3 Beijing Content Molecular Diagnostics Point of Care Product and Solutions
2.23.4 Beijing Content Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Beijing Content Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Molecular Diagnostics Point of Care Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Molecular Diagnostics Point of Care by Company Revenue
3.2.2 Top 3 Molecular Diagnostics Point of Care Players Market Share in 2022
3.2.3 Top 6 Molecular Diagnostics Point of Care Players Market Share in 2022
3.3 Molecular Diagnostics Point of Care Market: Overall Company Footprint Analysis
3.3.1 Molecular Diagnostics Point of Care Market: Region Footprint
3.3.2 Molecular Diagnostics Point of Care Market: Company Product Type Footprint
3.3.3 Molecular Diagnostics Point of Care Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Molecular Diagnostics Point of Care Consumption Value and Market Share by Type (2018-2023)
4.2 Global Molecular Diagnostics Point of Care Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Molecular Diagnostics Point of Care Consumption Value Market Share by Application (2018-2023)
5.2 Global Molecular Diagnostics Point of Care Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Molecular Diagnostics Point of Care Consumption Value by Type (2018-2029)
6.2 North America Molecular Diagnostics Point of Care Consumption Value by Application (2018-2029)
6.3 North America Molecular Diagnostics Point of Care Market Size by Country
6.3.1 North America Molecular Diagnostics Point of Care Consumption Value by Country (2018-2029)
6.3.2 United States Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
6.3.3 Canada Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
6.3.4 Mexico Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Molecular Diagnostics Point of Care Consumption Value by Type (2018-2029)
7.2 Europe Molecular Diagnostics Point of Care Consumption Value by Application (2018-2029)
7.3 Europe Molecular Diagnostics Point of Care Market Size by Country
7.3.1 Europe Molecular Diagnostics Point of Care Consumption Value by Country (2018-2029)
7.3.2 Germany Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
7.3.3 France Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
7.3.5 Russia Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
7.3.6 Italy Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Molecular Diagnostics Point of Care Market Size by Region
8.3.1 Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Region (2018-2029)
8.3.2 China Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
8.3.3 Japan Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
8.3.4 South Korea Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
8.3.5 India Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
8.3.7 Australia Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Molecular Diagnostics Point of Care Consumption Value by Type (2018-2029)
9.2 South America Molecular Diagnostics Point of Care Consumption Value by Application (2018-2029)
9.3 South America Molecular Diagnostics Point of Care Market Size by Country
9.3.1 South America Molecular Diagnostics Point of Care Consumption Value by Country (2018-2029)
9.3.2 Brazil Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
9.3.3 Argentina Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Molecular Diagnostics Point of Care Market Size by Country
10.3.1 Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Country (2018-2029)
10.3.2 Turkey Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
10.3.4 UAE Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Molecular Diagnostics Point of Care Market Drivers
11.2 Molecular Diagnostics Point of Care Market Restraints
11.3 Molecular Diagnostics Point of Care Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Molecular Diagnostics Point of Care Industry Chain
12.2 Molecular Diagnostics Point of Care Upstream Analysis
12.3 Molecular Diagnostics Point of Care Midstream Analysis
12.4 Molecular Diagnostics Point of Care Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Molecular Diagnostics Point of Care
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Molecular Diagnostics Point of Care by Type
1.3.1 Overview: Global Molecular Diagnostics Point of Care Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Molecular Diagnostics Point of Care Consumption Value Market Share by Type in 2022
1.3.3 Assays and Kits
1.3.4 Instruments and Analyzers
1.3.5 Software and Services
1.3.6 Others
1.4 Global Molecular Diagnostics Point of Care Market by Application
1.4.1 Overview: Global Molecular Diagnostics Point of Care Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Tumor
1.4.3 Hematology
1.4.4 Endocrinology
1.4.5 Infectious Disease
1.4.6 Others
1.5 Global Molecular Diagnostics Point of Care Market Size & Forecast
1.6 Global Molecular Diagnostics Point of Care Market Size and Forecast by Region
1.6.1 Global Molecular Diagnostics Point of Care Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Molecular Diagnostics Point of Care Market Size by Region, (2018-2029)
1.6.3 North America Molecular Diagnostics Point of Care Market Size and Prospect (2018-2029)
1.6.4 Europe Molecular Diagnostics Point of Care Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Molecular Diagnostics Point of Care Market Size and Prospect (2018-2029)
1.6.6 South America Molecular Diagnostics Point of Care Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Molecular Diagnostics Point of Care Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Product and Solutions
2.1.4 Abbott Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Abaxis
2.2.1 Abaxis Details
2.2.2 Abaxis Major Business
2.2.3 Abaxis Molecular Diagnostics Point of Care Product and Solutions
2.2.4 Abaxis Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abaxis Recent Developments and Future Plans
2.3 Bayer Healthcare
2.3.1 Bayer Healthcare Details
2.3.2 Bayer Healthcare Major Business
2.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Product and Solutions
2.3.4 Bayer Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bayer Healthcare Recent Developments and Future Plans
2.4 Bio-Rad Laboratories
2.4.1 Bio-Rad Laboratories Details
2.4.2 Bio-Rad Laboratories Major Business
2.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Product and Solutions
2.4.4 Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.5 Becton Dickinson and Company
2.5.1 Becton Dickinson and Company Details
2.5.2 Becton Dickinson and Company Major Business
2.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Product and Solutions
2.5.4 Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Becton Dickinson and Company Recent Developments and Future Plans
2.6 Binx Health
2.6.1 Binx Health Details
2.6.2 Binx Health Major Business
2.6.3 Binx Health Molecular Diagnostics Point of Care Product and Solutions
2.6.4 Binx Health Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Binx Health Recent Developments and Future Plans
2.7 BioMerieux
2.7.1 BioMerieux Details
2.7.2 BioMerieux Major Business
2.7.3 BioMerieux Molecular Diagnostics Point of Care Product and Solutions
2.7.4 BioMerieux Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 BioMerieux Recent Developments and Future Plans
2.8 Co-Diagnostics
2.8.1 Co-Diagnostics Details
2.8.2 Co-Diagnostics Major Business
2.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Product and Solutions
2.8.4 Co-Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Co-Diagnostics Recent Developments and Future Plans
2.9 DanaherCorporation
2.9.1 DanaherCorporation Details
2.9.2 DanaherCorporation Major Business
2.9.3 DanaherCorporation Molecular Diagnostics Point of Care Product and Solutions
2.9.4 DanaherCorporation Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 DanaherCorporation Recent Developments and Future Plans
2.10 Dako
2.10.1 Dako Details
2.10.2 Dako Major Business
2.10.3 Dako Molecular Diagnostics Point of Care Product and Solutions
2.10.4 Dako Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Dako Recent Developments and Future Plans
2.11 F. Hoffmann
2.11.1 F. Hoffmann Details
2.11.2 F. Hoffmann Major Business
2.11.3 F. Hoffmann Molecular Diagnostics Point of Care Product and Solutions
2.11.4 F. Hoffmann Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 F. Hoffmann Recent Developments and Future Plans
2.12 OraSure Technologies
2.12.1 OraSure Technologies Details
2.12.2 OraSure Technologies Major Business
2.12.3 OraSure Technologies Molecular Diagnostics Point of Care Product and Solutions
2.12.4 OraSure Technologies Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 OraSure Technologies Recent Developments and Future Plans
2.13 Roche Diagnostics
2.13.1 Roche Diagnostics Details
2.13.2 Roche Diagnostics Major Business
2.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Product and Solutions
2.13.4 Roche Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Roche Diagnostics Recent Developments and Future Plans
2.14 Nipro Diagnostics
2.14.1 Nipro Diagnostics Details
2.14.2 Nipro Diagnostics Major Business
2.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Product and Solutions
2.14.4 Nipro Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Nipro Diagnostics Recent Developments and Future Plans
2.15 Genestat
2.15.1 Genestat Details
2.15.2 Genestat Major Business
2.15.3 Genestat Molecular Diagnostics Point of Care Product and Solutions
2.15.4 Genestat Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Genestat Recent Developments and Future Plans
2.16 Meridian Bioscience
2.16.1 Meridian Bioscience Details
2.16.2 Meridian Bioscience Major Business
2.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Product and Solutions
2.16.4 Meridian Bioscience Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Meridian Bioscience Recent Developments and Future Plans
2.17 Molbio Diagnostics
2.17.1 Molbio Diagnostics Details
2.17.2 Molbio Diagnostics Major Business
2.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Product and Solutions
2.17.4 Molbio Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Molbio Diagnostics Recent Developments and Future Plans
2.18 Siemens Healthcare
2.18.1 Siemens Healthcare Details
2.18.2 Siemens Healthcare Major Business
2.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Product and Solutions
2.18.4 Siemens Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Siemens Healthcare Recent Developments and Future Plans
2.19 Thermo Fisher Scientific
2.19.1 Thermo Fisher Scientific Details
2.19.2 Thermo Fisher Scientific Major Business
2.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Product and Solutions
2.19.4 Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.20 Visby Medical
2.20.1 Visby Medical Details
2.20.2 Visby Medical Major Business
2.20.3 Visby Medical Molecular Diagnostics Point of Care Product and Solutions
2.20.4 Visby Medical Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Visby Medical Recent Developments and Future Plans
2.21 Wuhan Easy Diagnosis Biomedicine
2.21.1 Wuhan Easy Diagnosis Biomedicine Details
2.21.2 Wuhan Easy Diagnosis Biomedicine Major Business
2.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product and Solutions
2.21.4 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Wuhan Easy Diagnosis Biomedicine Recent Developments and Future Plans
2.22 Beijing Tiandz
2.22.1 Beijing Tiandz Details
2.22.2 Beijing Tiandz Major Business
2.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Product and Solutions
2.22.4 Beijing Tiandz Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Beijing Tiandz Recent Developments and Future Plans
2.23 Beijing Content
2.23.1 Beijing Content Details
2.23.2 Beijing Content Major Business
2.23.3 Beijing Content Molecular Diagnostics Point of Care Product and Solutions
2.23.4 Beijing Content Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Beijing Content Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Molecular Diagnostics Point of Care Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Molecular Diagnostics Point of Care by Company Revenue
3.2.2 Top 3 Molecular Diagnostics Point of Care Players Market Share in 2022
3.2.3 Top 6 Molecular Diagnostics Point of Care Players Market Share in 2022
3.3 Molecular Diagnostics Point of Care Market: Overall Company Footprint Analysis
3.3.1 Molecular Diagnostics Point of Care Market: Region Footprint
3.3.2 Molecular Diagnostics Point of Care Market: Company Product Type Footprint
3.3.3 Molecular Diagnostics Point of Care Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Molecular Diagnostics Point of Care Consumption Value and Market Share by Type (2018-2023)
4.2 Global Molecular Diagnostics Point of Care Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Molecular Diagnostics Point of Care Consumption Value Market Share by Application (2018-2023)
5.2 Global Molecular Diagnostics Point of Care Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Molecular Diagnostics Point of Care Consumption Value by Type (2018-2029)
6.2 North America Molecular Diagnostics Point of Care Consumption Value by Application (2018-2029)
6.3 North America Molecular Diagnostics Point of Care Market Size by Country
6.3.1 North America Molecular Diagnostics Point of Care Consumption Value by Country (2018-2029)
6.3.2 United States Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
6.3.3 Canada Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
6.3.4 Mexico Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Molecular Diagnostics Point of Care Consumption Value by Type (2018-2029)
7.2 Europe Molecular Diagnostics Point of Care Consumption Value by Application (2018-2029)
7.3 Europe Molecular Diagnostics Point of Care Market Size by Country
7.3.1 Europe Molecular Diagnostics Point of Care Consumption Value by Country (2018-2029)
7.3.2 Germany Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
7.3.3 France Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
7.3.5 Russia Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
7.3.6 Italy Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Molecular Diagnostics Point of Care Market Size by Region
8.3.1 Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Region (2018-2029)
8.3.2 China Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
8.3.3 Japan Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
8.3.4 South Korea Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
8.3.5 India Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
8.3.7 Australia Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Molecular Diagnostics Point of Care Consumption Value by Type (2018-2029)
9.2 South America Molecular Diagnostics Point of Care Consumption Value by Application (2018-2029)
9.3 South America Molecular Diagnostics Point of Care Market Size by Country
9.3.1 South America Molecular Diagnostics Point of Care Consumption Value by Country (2018-2029)
9.3.2 Brazil Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
9.3.3 Argentina Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Molecular Diagnostics Point of Care Market Size by Country
10.3.1 Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Country (2018-2029)
10.3.2 Turkey Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
10.3.4 UAE Molecular Diagnostics Point of Care Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Molecular Diagnostics Point of Care Market Drivers
11.2 Molecular Diagnostics Point of Care Market Restraints
11.3 Molecular Diagnostics Point of Care Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Molecular Diagnostics Point of Care Industry Chain
12.2 Molecular Diagnostics Point of Care Upstream Analysis
12.3 Molecular Diagnostics Point of Care Midstream Analysis
12.4 Molecular Diagnostics Point of Care Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Molecular Diagnostics Point of Care Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Molecular Diagnostics Point of Care Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Molecular Diagnostics Point of Care Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Molecular Diagnostics Point of Care Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Molecular Diagnostics Point of Care Product and Solutions
Table 8. Abbott Laboratories Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abbott Laboratories Recent Developments and Future Plans
Table 10. Abaxis Company Information, Head Office, and Major Competitors
Table 11. Abaxis Major Business
Table 12. Abaxis Molecular Diagnostics Point of Care Product and Solutions
Table 13. Abaxis Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Abaxis Recent Developments and Future Plans
Table 15. Bayer Healthcare Company Information, Head Office, and Major Competitors
Table 16. Bayer Healthcare Major Business
Table 17. Bayer Healthcare Molecular Diagnostics Point of Care Product and Solutions
Table 18. Bayer Healthcare Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Bayer Healthcare Recent Developments and Future Plans
Table 20. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 21. Bio-Rad Laboratories Major Business
Table 22. Bio-Rad Laboratories Molecular Diagnostics Point of Care Product and Solutions
Table 23. Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bio-Rad Laboratories Recent Developments and Future Plans
Table 25. Becton Dickinson and Company Company Information, Head Office, and Major Competitors
Table 26. Becton Dickinson and Company Major Business
Table 27. Becton Dickinson and Company Molecular Diagnostics Point of Care Product and Solutions
Table 28. Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Becton Dickinson and Company Recent Developments and Future Plans
Table 30. Binx Health Company Information, Head Office, and Major Competitors
Table 31. Binx Health Major Business
Table 32. Binx Health Molecular Diagnostics Point of Care Product and Solutions
Table 33. Binx Health Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Binx Health Recent Developments and Future Plans
Table 35. BioMerieux Company Information, Head Office, and Major Competitors
Table 36. BioMerieux Major Business
Table 37. BioMerieux Molecular Diagnostics Point of Care Product and Solutions
Table 38. BioMerieux Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. BioMerieux Recent Developments and Future Plans
Table 40. Co-Diagnostics Company Information, Head Office, and Major Competitors
Table 41. Co-Diagnostics Major Business
Table 42. Co-Diagnostics Molecular Diagnostics Point of Care Product and Solutions
Table 43. Co-Diagnostics Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Co-Diagnostics Recent Developments and Future Plans
Table 45. DanaherCorporation Company Information, Head Office, and Major Competitors
Table 46. DanaherCorporation Major Business
Table 47. DanaherCorporation Molecular Diagnostics Point of Care Product and Solutions
Table 48. DanaherCorporation Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. DanaherCorporation Recent Developments and Future Plans
Table 50. Dako Company Information, Head Office, and Major Competitors
Table 51. Dako Major Business
Table 52. Dako Molecular Diagnostics Point of Care Product and Solutions
Table 53. Dako Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Dako Recent Developments and Future Plans
Table 55. F. Hoffmann Company Information, Head Office, and Major Competitors
Table 56. F. Hoffmann Major Business
Table 57. F. Hoffmann Molecular Diagnostics Point of Care Product and Solutions
Table 58. F. Hoffmann Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. F. Hoffmann Recent Developments and Future Plans
Table 60. OraSure Technologies Company Information, Head Office, and Major Competitors
Table 61. OraSure Technologies Major Business
Table 62. OraSure Technologies Molecular Diagnostics Point of Care Product and Solutions
Table 63. OraSure Technologies Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. OraSure Technologies Recent Developments and Future Plans
Table 65. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 66. Roche Diagnostics Major Business
Table 67. Roche Diagnostics Molecular Diagnostics Point of Care Product and Solutions
Table 68. Roche Diagnostics Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Roche Diagnostics Recent Developments and Future Plans
Table 70. Nipro Diagnostics Company Information, Head Office, and Major Competitors
Table 71. Nipro Diagnostics Major Business
Table 72. Nipro Diagnostics Molecular Diagnostics Point of Care Product and Solutions
Table 73. Nipro Diagnostics Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Nipro Diagnostics Recent Developments and Future Plans
Table 75. Genestat Company Information, Head Office, and Major Competitors
Table 76. Genestat Major Business
Table 77. Genestat Molecular Diagnostics Point of Care Product and Solutions
Table 78. Genestat Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Genestat Recent Developments and Future Plans
Table 80. Meridian Bioscience Company Information, Head Office, and Major Competitors
Table 81. Meridian Bioscience Major Business
Table 82. Meridian Bioscience Molecular Diagnostics Point of Care Product and Solutions
Table 83. Meridian Bioscience Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Meridian Bioscience Recent Developments and Future Plans
Table 85. Molbio Diagnostics Company Information, Head Office, and Major Competitors
Table 86. Molbio Diagnostics Major Business
Table 87. Molbio Diagnostics Molecular Diagnostics Point of Care Product and Solutions
Table 88. Molbio Diagnostics Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Molbio Diagnostics Recent Developments and Future Plans
Table 90. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 91. Siemens Healthcare Major Business
Table 92. Siemens Healthcare Molecular Diagnostics Point of Care Product and Solutions
Table 93. Siemens Healthcare Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Siemens Healthcare Recent Developments and Future Plans
Table 95. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 96. Thermo Fisher Scientific Major Business
Table 97. Thermo Fisher Scientific Molecular Diagnostics Point of Care Product and Solutions
Table 98. Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Thermo Fisher Scientific Recent Developments and Future Plans
Table 100. Visby Medical Company Information, Head Office, and Major Competitors
Table 101. Visby Medical Major Business
Table 102. Visby Medical Molecular Diagnostics Point of Care Product and Solutions
Table 103. Visby Medical Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Visby Medical Recent Developments and Future Plans
Table 105. Wuhan Easy Diagnosis Biomedicine Company Information, Head Office, and Major Competitors
Table 106. Wuhan Easy Diagnosis Biomedicine Major Business
Table 107. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product and Solutions
Table 108. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Wuhan Easy Diagnosis Biomedicine Recent Developments and Future Plans
Table 110. Beijing Tiandz Company Information, Head Office, and Major Competitors
Table 111. Beijing Tiandz Major Business
Table 112. Beijing Tiandz Molecular Diagnostics Point of Care Product and Solutions
Table 113. Beijing Tiandz Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Beijing Tiandz Recent Developments and Future Plans
Table 115. Beijing Content Company Information, Head Office, and Major Competitors
Table 116. Beijing Content Major Business
Table 117. Beijing Content Molecular Diagnostics Point of Care Product and Solutions
Table 118. Beijing Content Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Beijing Content Recent Developments and Future Plans
Table 120. Global Molecular Diagnostics Point of Care Revenue (USD Million) by Players (2018-2023)
Table 121. Global Molecular Diagnostics Point of Care Revenue Share by Players (2018-2023)
Table 122. Breakdown of Molecular Diagnostics Point of Care by Company Type (Tier 1, Tier 2, and Tier 3)
Table 123. Market Position of Players in Molecular Diagnostics Point of Care, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 124. Head Office of Key Molecular Diagnostics Point of Care Players
Table 125. Molecular Diagnostics Point of Care Market: Company Product Type Footprint
Table 126. Molecular Diagnostics Point of Care Market: Company Product Application Footprint
Table 127. Molecular Diagnostics Point of Care New Market Entrants and Barriers to Market Entry
Table 128. Molecular Diagnostics Point of Care Mergers, Acquisition, Agreements, and Collaborations
Table 129. Global Molecular Diagnostics Point of Care Consumption Value (USD Million) by Type (2018-2023)
Table 130. Global Molecular Diagnostics Point of Care Consumption Value Share by Type (2018-2023)
Table 131. Global Molecular Diagnostics Point of Care Consumption Value Forecast by Type (2024-2029)
Table 132. Global Molecular Diagnostics Point of Care Consumption Value by Application (2018-2023)
Table 133. Global Molecular Diagnostics Point of Care Consumption Value Forecast by Application (2024-2029)
Table 134. North America Molecular Diagnostics Point of Care Consumption Value by Type (2018-2023) & (USD Million)
Table 135. North America Molecular Diagnostics Point of Care Consumption Value by Type (2024-2029) & (USD Million)
Table 136. North America Molecular Diagnostics Point of Care Consumption Value by Application (2018-2023) & (USD Million)
Table 137. North America Molecular Diagnostics Point of Care Consumption Value by Application (2024-2029) & (USD Million)
Table 138. North America Molecular Diagnostics Point of Care Consumption Value by Country (2018-2023) & (USD Million)
Table 139. North America Molecular Diagnostics Point of Care Consumption Value by Country (2024-2029) & (USD Million)
Table 140. Europe Molecular Diagnostics Point of Care Consumption Value by Type (2018-2023) & (USD Million)
Table 141. Europe Molecular Diagnostics Point of Care Consumption Value by Type (2024-2029) & (USD Million)
Table 142. Europe Molecular Diagnostics Point of Care Consumption Value by Application (2018-2023) & (USD Million)
Table 143. Europe Molecular Diagnostics Point of Care Consumption Value by Application (2024-2029) & (USD Million)
Table 144. Europe Molecular Diagnostics Point of Care Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Molecular Diagnostics Point of Care Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Type (2018-2023) & (USD Million)
Table 147. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Type (2024-2029) & (USD Million)
Table 148. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Application (2018-2023) & (USD Million)
Table 149. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Application (2024-2029) & (USD Million)
Table 150. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Region (2018-2023) & (USD Million)
Table 151. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Region (2024-2029) & (USD Million)
Table 152. South America Molecular Diagnostics Point of Care Consumption Value by Type (2018-2023) & (USD Million)
Table 153. South America Molecular Diagnostics Point of Care Consumption Value by Type (2024-2029) & (USD Million)
Table 154. South America Molecular Diagnostics Point of Care Consumption Value by Application (2018-2023) & (USD Million)
Table 155. South America Molecular Diagnostics Point of Care Consumption Value by Application (2024-2029) & (USD Million)
Table 156. South America Molecular Diagnostics Point of Care Consumption Value by Country (2018-2023) & (USD Million)
Table 157. South America Molecular Diagnostics Point of Care Consumption Value by Country (2024-2029) & (USD Million)
Table 158. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Type (2018-2023) & (USD Million)
Table 159. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Type (2024-2029) & (USD Million)
Table 160. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Application (2018-2023) & (USD Million)
Table 161. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Application (2024-2029) & (USD Million)
Table 162. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Country (2018-2023) & (USD Million)
Table 163. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Country (2024-2029) & (USD Million)
Table 164. Molecular Diagnostics Point of Care Raw Material
Table 165. Key Suppliers of Molecular Diagnostics Point of Care Raw Materials
Table 1. Global Molecular Diagnostics Point of Care Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Molecular Diagnostics Point of Care Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Molecular Diagnostics Point of Care Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Molecular Diagnostics Point of Care Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Molecular Diagnostics Point of Care Product and Solutions
Table 8. Abbott Laboratories Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abbott Laboratories Recent Developments and Future Plans
Table 10. Abaxis Company Information, Head Office, and Major Competitors
Table 11. Abaxis Major Business
Table 12. Abaxis Molecular Diagnostics Point of Care Product and Solutions
Table 13. Abaxis Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Abaxis Recent Developments and Future Plans
Table 15. Bayer Healthcare Company Information, Head Office, and Major Competitors
Table 16. Bayer Healthcare Major Business
Table 17. Bayer Healthcare Molecular Diagnostics Point of Care Product and Solutions
Table 18. Bayer Healthcare Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Bayer Healthcare Recent Developments and Future Plans
Table 20. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 21. Bio-Rad Laboratories Major Business
Table 22. Bio-Rad Laboratories Molecular Diagnostics Point of Care Product and Solutions
Table 23. Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bio-Rad Laboratories Recent Developments and Future Plans
Table 25. Becton Dickinson and Company Company Information, Head Office, and Major Competitors
Table 26. Becton Dickinson and Company Major Business
Table 27. Becton Dickinson and Company Molecular Diagnostics Point of Care Product and Solutions
Table 28. Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Becton Dickinson and Company Recent Developments and Future Plans
Table 30. Binx Health Company Information, Head Office, and Major Competitors
Table 31. Binx Health Major Business
Table 32. Binx Health Molecular Diagnostics Point of Care Product and Solutions
Table 33. Binx Health Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Binx Health Recent Developments and Future Plans
Table 35. BioMerieux Company Information, Head Office, and Major Competitors
Table 36. BioMerieux Major Business
Table 37. BioMerieux Molecular Diagnostics Point of Care Product and Solutions
Table 38. BioMerieux Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. BioMerieux Recent Developments and Future Plans
Table 40. Co-Diagnostics Company Information, Head Office, and Major Competitors
Table 41. Co-Diagnostics Major Business
Table 42. Co-Diagnostics Molecular Diagnostics Point of Care Product and Solutions
Table 43. Co-Diagnostics Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Co-Diagnostics Recent Developments and Future Plans
Table 45. DanaherCorporation Company Information, Head Office, and Major Competitors
Table 46. DanaherCorporation Major Business
Table 47. DanaherCorporation Molecular Diagnostics Point of Care Product and Solutions
Table 48. DanaherCorporation Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. DanaherCorporation Recent Developments and Future Plans
Table 50. Dako Company Information, Head Office, and Major Competitors
Table 51. Dako Major Business
Table 52. Dako Molecular Diagnostics Point of Care Product and Solutions
Table 53. Dako Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Dako Recent Developments and Future Plans
Table 55. F. Hoffmann Company Information, Head Office, and Major Competitors
Table 56. F. Hoffmann Major Business
Table 57. F. Hoffmann Molecular Diagnostics Point of Care Product and Solutions
Table 58. F. Hoffmann Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. F. Hoffmann Recent Developments and Future Plans
Table 60. OraSure Technologies Company Information, Head Office, and Major Competitors
Table 61. OraSure Technologies Major Business
Table 62. OraSure Technologies Molecular Diagnostics Point of Care Product and Solutions
Table 63. OraSure Technologies Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. OraSure Technologies Recent Developments and Future Plans
Table 65. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 66. Roche Diagnostics Major Business
Table 67. Roche Diagnostics Molecular Diagnostics Point of Care Product and Solutions
Table 68. Roche Diagnostics Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Roche Diagnostics Recent Developments and Future Plans
Table 70. Nipro Diagnostics Company Information, Head Office, and Major Competitors
Table 71. Nipro Diagnostics Major Business
Table 72. Nipro Diagnostics Molecular Diagnostics Point of Care Product and Solutions
Table 73. Nipro Diagnostics Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Nipro Diagnostics Recent Developments and Future Plans
Table 75. Genestat Company Information, Head Office, and Major Competitors
Table 76. Genestat Major Business
Table 77. Genestat Molecular Diagnostics Point of Care Product and Solutions
Table 78. Genestat Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Genestat Recent Developments and Future Plans
Table 80. Meridian Bioscience Company Information, Head Office, and Major Competitors
Table 81. Meridian Bioscience Major Business
Table 82. Meridian Bioscience Molecular Diagnostics Point of Care Product and Solutions
Table 83. Meridian Bioscience Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Meridian Bioscience Recent Developments and Future Plans
Table 85. Molbio Diagnostics Company Information, Head Office, and Major Competitors
Table 86. Molbio Diagnostics Major Business
Table 87. Molbio Diagnostics Molecular Diagnostics Point of Care Product and Solutions
Table 88. Molbio Diagnostics Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Molbio Diagnostics Recent Developments and Future Plans
Table 90. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 91. Siemens Healthcare Major Business
Table 92. Siemens Healthcare Molecular Diagnostics Point of Care Product and Solutions
Table 93. Siemens Healthcare Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Siemens Healthcare Recent Developments and Future Plans
Table 95. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 96. Thermo Fisher Scientific Major Business
Table 97. Thermo Fisher Scientific Molecular Diagnostics Point of Care Product and Solutions
Table 98. Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Thermo Fisher Scientific Recent Developments and Future Plans
Table 100. Visby Medical Company Information, Head Office, and Major Competitors
Table 101. Visby Medical Major Business
Table 102. Visby Medical Molecular Diagnostics Point of Care Product and Solutions
Table 103. Visby Medical Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Visby Medical Recent Developments and Future Plans
Table 105. Wuhan Easy Diagnosis Biomedicine Company Information, Head Office, and Major Competitors
Table 106. Wuhan Easy Diagnosis Biomedicine Major Business
Table 107. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product and Solutions
Table 108. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Wuhan Easy Diagnosis Biomedicine Recent Developments and Future Plans
Table 110. Beijing Tiandz Company Information, Head Office, and Major Competitors
Table 111. Beijing Tiandz Major Business
Table 112. Beijing Tiandz Molecular Diagnostics Point of Care Product and Solutions
Table 113. Beijing Tiandz Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Beijing Tiandz Recent Developments and Future Plans
Table 115. Beijing Content Company Information, Head Office, and Major Competitors
Table 116. Beijing Content Major Business
Table 117. Beijing Content Molecular Diagnostics Point of Care Product and Solutions
Table 118. Beijing Content Molecular Diagnostics Point of Care Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Beijing Content Recent Developments and Future Plans
Table 120. Global Molecular Diagnostics Point of Care Revenue (USD Million) by Players (2018-2023)
Table 121. Global Molecular Diagnostics Point of Care Revenue Share by Players (2018-2023)
Table 122. Breakdown of Molecular Diagnostics Point of Care by Company Type (Tier 1, Tier 2, and Tier 3)
Table 123. Market Position of Players in Molecular Diagnostics Point of Care, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 124. Head Office of Key Molecular Diagnostics Point of Care Players
Table 125. Molecular Diagnostics Point of Care Market: Company Product Type Footprint
Table 126. Molecular Diagnostics Point of Care Market: Company Product Application Footprint
Table 127. Molecular Diagnostics Point of Care New Market Entrants and Barriers to Market Entry
Table 128. Molecular Diagnostics Point of Care Mergers, Acquisition, Agreements, and Collaborations
Table 129. Global Molecular Diagnostics Point of Care Consumption Value (USD Million) by Type (2018-2023)
Table 130. Global Molecular Diagnostics Point of Care Consumption Value Share by Type (2018-2023)
Table 131. Global Molecular Diagnostics Point of Care Consumption Value Forecast by Type (2024-2029)
Table 132. Global Molecular Diagnostics Point of Care Consumption Value by Application (2018-2023)
Table 133. Global Molecular Diagnostics Point of Care Consumption Value Forecast by Application (2024-2029)
Table 134. North America Molecular Diagnostics Point of Care Consumption Value by Type (2018-2023) & (USD Million)
Table 135. North America Molecular Diagnostics Point of Care Consumption Value by Type (2024-2029) & (USD Million)
Table 136. North America Molecular Diagnostics Point of Care Consumption Value by Application (2018-2023) & (USD Million)
Table 137. North America Molecular Diagnostics Point of Care Consumption Value by Application (2024-2029) & (USD Million)
Table 138. North America Molecular Diagnostics Point of Care Consumption Value by Country (2018-2023) & (USD Million)
Table 139. North America Molecular Diagnostics Point of Care Consumption Value by Country (2024-2029) & (USD Million)
Table 140. Europe Molecular Diagnostics Point of Care Consumption Value by Type (2018-2023) & (USD Million)
Table 141. Europe Molecular Diagnostics Point of Care Consumption Value by Type (2024-2029) & (USD Million)
Table 142. Europe Molecular Diagnostics Point of Care Consumption Value by Application (2018-2023) & (USD Million)
Table 143. Europe Molecular Diagnostics Point of Care Consumption Value by Application (2024-2029) & (USD Million)
Table 144. Europe Molecular Diagnostics Point of Care Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Molecular Diagnostics Point of Care Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Type (2018-2023) & (USD Million)
Table 147. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Type (2024-2029) & (USD Million)
Table 148. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Application (2018-2023) & (USD Million)
Table 149. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Application (2024-2029) & (USD Million)
Table 150. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Region (2018-2023) & (USD Million)
Table 151. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value by Region (2024-2029) & (USD Million)
Table 152. South America Molecular Diagnostics Point of Care Consumption Value by Type (2018-2023) & (USD Million)
Table 153. South America Molecular Diagnostics Point of Care Consumption Value by Type (2024-2029) & (USD Million)
Table 154. South America Molecular Diagnostics Point of Care Consumption Value by Application (2018-2023) & (USD Million)
Table 155. South America Molecular Diagnostics Point of Care Consumption Value by Application (2024-2029) & (USD Million)
Table 156. South America Molecular Diagnostics Point of Care Consumption Value by Country (2018-2023) & (USD Million)
Table 157. South America Molecular Diagnostics Point of Care Consumption Value by Country (2024-2029) & (USD Million)
Table 158. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Type (2018-2023) & (USD Million)
Table 159. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Type (2024-2029) & (USD Million)
Table 160. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Application (2018-2023) & (USD Million)
Table 161. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Application (2024-2029) & (USD Million)
Table 162. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Country (2018-2023) & (USD Million)
Table 163. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value by Country (2024-2029) & (USD Million)
Table 164. Molecular Diagnostics Point of Care Raw Material
Table 165. Key Suppliers of Molecular Diagnostics Point of Care Raw Materials
LIST OF FIGURES
Figure 1. Molecular Diagnostics Point of Care Picture
Figure 2. Global Molecular Diagnostics Point of Care Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Molecular Diagnostics Point of Care Consumption Value Market Share by Type in 2022
Figure 4. Assays and Kits
Figure 5. Instruments and Analyzers
Figure 6. Software and Services
Figure 7. Others
Figure 8. Global Molecular Diagnostics Point of Care Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Molecular Diagnostics Point of Care Consumption Value Market Share by Application in 2022
Figure 10. Tumor Picture
Figure 11. Hematology Picture
Figure 12. Endocrinology Picture
Figure 13. Infectious Disease Picture
Figure 14. Others Picture
Figure 15. Global Molecular Diagnostics Point of Care Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Molecular Diagnostics Point of Care Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Molecular Diagnostics Point of Care Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Molecular Diagnostics Point of Care Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Molecular Diagnostics Point of Care Consumption Value Market Share by Region in 2022
Figure 20. North America Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Molecular Diagnostics Point of Care Revenue Share by Players in 2022
Figure 26. Molecular Diagnostics Point of Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Molecular Diagnostics Point of Care Market Share in 2022
Figure 28. Global Top 6 Players Molecular Diagnostics Point of Care Market Share in 2022
Figure 29. Global Molecular Diagnostics Point of Care Consumption Value Share by Type (2018-2023)
Figure 30. Global Molecular Diagnostics Point of Care Market Share Forecast by Type (2024-2029)
Figure 31. Global Molecular Diagnostics Point of Care Consumption Value Share by Application (2018-2023)
Figure 32. Global Molecular Diagnostics Point of Care Market Share Forecast by Application (2024-2029)
Figure 33. North America Molecular Diagnostics Point of Care Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Molecular Diagnostics Point of Care Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Molecular Diagnostics Point of Care Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Molecular Diagnostics Point of Care Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Molecular Diagnostics Point of Care Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Molecular Diagnostics Point of Care Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 43. France Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value Market Share by Region (2018-2029)
Figure 50. China Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 53. India Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Molecular Diagnostics Point of Care Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Molecular Diagnostics Point of Care Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Molecular Diagnostics Point of Care Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Molecular Diagnostics Point of Care Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Molecular Diagnostics Point of Care Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Molecular Diagnostics Point of Care Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 67. Molecular Diagnostics Point of Care Market Drivers
Figure 68. Molecular Diagnostics Point of Care Market Restraints
Figure 69. Molecular Diagnostics Point of Care Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Molecular Diagnostics Point of Care in 2022
Figure 72. Manufacturing Process Analysis of Molecular Diagnostics Point of Care
Figure 73. Molecular Diagnostics Point of Care Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Molecular Diagnostics Point of Care Picture
Figure 2. Global Molecular Diagnostics Point of Care Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Molecular Diagnostics Point of Care Consumption Value Market Share by Type in 2022
Figure 4. Assays and Kits
Figure 5. Instruments and Analyzers
Figure 6. Software and Services
Figure 7. Others
Figure 8. Global Molecular Diagnostics Point of Care Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Molecular Diagnostics Point of Care Consumption Value Market Share by Application in 2022
Figure 10. Tumor Picture
Figure 11. Hematology Picture
Figure 12. Endocrinology Picture
Figure 13. Infectious Disease Picture
Figure 14. Others Picture
Figure 15. Global Molecular Diagnostics Point of Care Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Molecular Diagnostics Point of Care Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Molecular Diagnostics Point of Care Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Molecular Diagnostics Point of Care Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Molecular Diagnostics Point of Care Consumption Value Market Share by Region in 2022
Figure 20. North America Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Molecular Diagnostics Point of Care Revenue Share by Players in 2022
Figure 26. Molecular Diagnostics Point of Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Molecular Diagnostics Point of Care Market Share in 2022
Figure 28. Global Top 6 Players Molecular Diagnostics Point of Care Market Share in 2022
Figure 29. Global Molecular Diagnostics Point of Care Consumption Value Share by Type (2018-2023)
Figure 30. Global Molecular Diagnostics Point of Care Market Share Forecast by Type (2024-2029)
Figure 31. Global Molecular Diagnostics Point of Care Consumption Value Share by Application (2018-2023)
Figure 32. Global Molecular Diagnostics Point of Care Market Share Forecast by Application (2024-2029)
Figure 33. North America Molecular Diagnostics Point of Care Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Molecular Diagnostics Point of Care Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Molecular Diagnostics Point of Care Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Molecular Diagnostics Point of Care Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Molecular Diagnostics Point of Care Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Molecular Diagnostics Point of Care Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 43. France Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Molecular Diagnostics Point of Care Consumption Value Market Share by Region (2018-2029)
Figure 50. China Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 53. India Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Molecular Diagnostics Point of Care Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Molecular Diagnostics Point of Care Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Molecular Diagnostics Point of Care Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Molecular Diagnostics Point of Care Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Molecular Diagnostics Point of Care Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Molecular Diagnostics Point of Care Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 67. Molecular Diagnostics Point of Care Market Drivers
Figure 68. Molecular Diagnostics Point of Care Market Restraints
Figure 69. Molecular Diagnostics Point of Care Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Molecular Diagnostics Point of Care in 2022
Figure 72. Manufacturing Process Analysis of Molecular Diagnostics Point of Care
Figure 73. Molecular Diagnostics Point of Care Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
